Shares Outstanding for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.25B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingShares OutstandingSwitch metric
Latest period
1.25B
YoY change
0.0%
5Y CAGR
-0.1%
Peak year (2007)
1.93B
Latest annual
1.25B
Shares Outstanding history chart for Gilead Sciences (GILD) from 1990 to 2025
Shares Outstanding history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 1.25B | 0.0% | ||
| 2024 | 1.25B | -0.2% | ||
| 2023 | 1.26B | -0.3% | ||
| 2022 | 1.26B | 0.0% | ||
| 2021 | 1.26B | -0.1% | ||
| 2020 | 1.26B | -1.1% | ||
| 2019 | 1.28B | -2.4% | ||
| 2018 | 1.31B | -0.8% | ||
| 2017 | 1.32B | -2.9% | ||
| 2016 | 1.36B | -10.7% | ||
| 2015 | 1.52B | -7.7% | ||
| 2014 | 1.65B | -2.8% | ||
| 2013 | 1.69B | +7.1% | ||
| 2012 | 1.58B | +0.1% | ||
| 2011 | 1.58B | -9.5% | ||
| 2010 | 1.75B | -6.5% | ||
| 2009 | 1.87B | -2.6% | ||
| 2008 | 1.92B | -0.6% | ||
| 2007 | 1.93B | +5.0% | ||
| 2006 | 1.84B | -3.2% | ||
| 2005 | 1.90B | +2.2% | ||
| 2004 | 1.86B | +15.4% | ||
| 2003 | 1.61B | -2.6% | ||
| 2002 | 1.65B | +2.1% | ||
| 2001 | 1.62B | +11.1% | ||
| 2000 | 1.46B | +6.3% | ||
| 1999 | 1.37B | +4.4% | ||
| 1998 | 1.31B | +26.2% | ||
| 1997 | 1.04B | +17.0% | ||
| 1996 | 889.15M | +30.6% | ||
| 1995 | 680.77M | +14.2% | ||
| 1994 | 595.94M | — | ||
| 1992 | 512.73M | +42.4% | ||
| 1991 | 360.00M | +18.1% | ||
| 1990 | 304.76M | — |
Shares Outstanding values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Gilead Sciences (GILD) reported diluted shares outstanding of 1.25B – edged up 0.0% year-over-year.
Across 2020–2025 (5 years), Gilead Sciences diluted shares outstanding produced a CAGR of -0.1% – with a net decline across the window.
Gilead Sciences diluted shares outstanding plunged from 1.93B in 2007 to 1.25B in 2025, a 34.9% drawdown.
Across the available history, diluted shares outstanding reached its high of 1.93B in 2007 and its low of 304.76M in 1990.
Gilead Sciences (GILD) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
Gilead Sciences Shares Outstanding by Year
Gilead Sciences Shares Outstanding 2025: 1.25B
Gilead Sciences diluted shares outstanding in 2025 was 1.25B, edged up 0.0% from 2024.
Gilead Sciences Shares Outstanding 2024: 1.25B
Gilead Sciences diluted shares outstanding in 2024 was 1.25B, edged down 0.2% below 2023.
Gilead Sciences Shares Outstanding 2023: 1.26B
Gilead Sciences diluted shares outstanding in 2023 was 1.26B, edged down 0.3% below 2022.
Gilead Sciences Shares Outstanding 2022: 1.26B
Gilead Sciences diluted shares outstanding in 2022 was 1.26B, edged up 0.0% from 2021.
Gilead Sciences Shares Outstanding 2021: 1.26B
Gilead Sciences diluted shares outstanding in 2021 was 1.26B.
See more financial history for Gilead Sciences (GILD).
Sector peers — Shares Outstanding
Companies in the same sector as Gilead Sciences, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Gilead Sciences's diluted shares outstanding?
- Latest reported diluted shares outstanding for Gilead Sciences (GILD) is 1.25B (period ending December 31, 2025).
How has Gilead Sciences diluted shares outstanding changed year-over-year?
- Gilead Sciences (GILD) diluted shares outstanding changed 0.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences diluted shares outstanding?
- Gilead Sciences (GILD) diluted shares outstanding compound annual growth rate is -0.1% over the most recent 5 years available.
When did Gilead Sciences diluted shares outstanding hit its highest annual value?
- Gilead Sciences diluted shares outstanding reached its highest annual value of 1.93B in 2007.
What was Gilead Sciences diluted shares outstanding in 2024?
- Gilead Sciences (GILD) diluted shares outstanding in 2024 was 1.25B.
What was Gilead Sciences diluted shares outstanding in 2025?
- Gilead Sciences (GILD) diluted shares outstanding in 2025 was 1.25B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.